(CG) Carlyle - Overview
Stock: Private Equity, Real Assets, Credit, Fund
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.65% |
| Yield on Cost 5y | 5.01% |
| Yield CAGR 5y | 8.78% |
| Payout Consistency | 91.5% |
| Payout Ratio | 35.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 37.6% |
| Relative Tail Risk | -2.32% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.29 |
| Alpha | -18.01 |
| Character TTM | |
|---|---|
| Beta | 1.717 |
| Beta Downside | 2.121 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.53% |
| CAGR/Max DD | 0.53 |
Description: CG Carlyle December 19, 2025
The Carlyle Group Inc. (NASDAQ: CG) is a global investment firm that operates across four primary platforms – Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions – deploying capital through both direct investments and fund-of-fund structures. Its direct-investment mandate spans a wide array of transaction types, including management-led leveraged buyouts, strategic minority stakes, structured credit, distressed assets, and venture-stage financings, targeting sectors ranging from industrial manufacturing and agribusiness to fintech, aerospace, and healthcare.
As of FY 2023, Carlyle reported approximately $426 billion in assets under management (AUM), reflecting a 12 % YoY increase driven largely by strong fundraising in its Real Assets and Private Equity segments. The firm’s revenue mix is roughly 55 % fee-based (management and performance fees) and 45 % investment income, with net income margins hovering around 15 % after adjusting for one-time gains. Key macro drivers for Carlyle’s pipeline include the current low-interest-rate environment that supports leveraged buyouts, heightened corporate-level cash generation fueling divestitures, and growing institutional demand for ESG-aligned infrastructure assets, especially in renewable energy and logistics.
For a deeper, data-rich view of Carlyle’s valuation dynamics and peer comparisons, you may find it worthwhile to explore the analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 661.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.09 > 0.02 and ΔFCF/TA -8.33 > 1.0 |
| NWC/Revenue: -56.75% < 20% (prev 83.71%; Δ -140.5% < -1%) |
| CFO/TA -0.09 > 3% & CFO -2.43b > Net Income 661.5m |
| Net Debt (9.40b) to EBITDA (1.15b): 8.16 < 3 |
| Current Ratio: 0.67 > 1.5 & < 3 |
| Outstanding Shares: last quarter (376.5m) vs 12m ago 3.02% < -2% |
| Gross Margin: 80.96% > 18% (prev 0.77%; Δ 8019 % > 0.5%) |
| Asset Turnover: 14.85% > 50% (prev 12.98%; Δ 1.87% > 0%) |
| Interest Coverage Ratio: 1.37 > 6 (EBITDA TTM 1.15b / Interest Expense TTM 702.9m) |
Altman Z'' 0.03
| A: -0.08 (Total Current Assets 4.26b - Total Current Liabilities 6.35b) / Total Assets 27.06b |
| B: 0.06 (Retained Earnings 1.62b / Total Assets 27.06b) |
| C: 0.04 (EBIT TTM 962.8m / Avg Total Assets 24.86b) |
| D: 0.08 (Book Value of Equity 1.62b / Total Liabilities 20.21b) |
| Altman-Z'' Score: 0.03 = B |
Beneish M -2.94
| DSRI: 0.82 (Receivables 1.00b/975.5m, Revenue 3.69b/2.94b) |
| GMI: 0.95 (GM 80.96% / 76.77%) |
| AQI: 0.97 (AQ_t 0.82 / AQ_t-1 0.85) |
| SGI: 1.26 (Revenue 3.69b / 2.94b) |
| TATA: 0.11 (NI 661.5m - CFO -2.43b) / TA 27.06b) |
| Beneish M-Score: -2.94 (Cap -4..+1) = A |
What is the price of CG shares?
Over the past week, the price has changed by -3.97%, over one month by -3.42%, over three months by +14.22% and over the past year by +11.39%.
Is CG a buy, sell or hold?
- StrongBuy: 4
- Buy: 3
- Hold: 10
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the CG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 69.9 | 18.9% |
| Analysts Target Price | 69.9 | 18.9% |
| ValueRay Target Price | 66 | 12.3% |
CG Fundamental Data Overview January 27, 2026
P/E Forward = 12.5313
P/S = 6.9087
P/B = 3.9302
P/EG = 0.8583
Revenue TTM = 3.69b USD
EBIT TTM = 962.8m USD
EBITDA TTM = 1.15b USD
Long Term Debt = 12.54b USD (estimated: total debt 12.66b - short term 118.7m)
Short Term Debt = 118.7m USD (from shortTermDebt, last quarter)
Debt = 12.66b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.40b USD (from netDebt column, last quarter)
Enterprise Value = 31.57b USD (22.17b + Debt 12.66b - CCE 3.26b)
Interest Coverage Ratio = 1.37 (Ebit TTM 962.8m / Interest Expense TTM 702.9m)
EV/FCF = -12.54x (Enterprise Value 31.57b / FCF TTM -2.52b)
FCF Yield = -7.97% (FCF TTM -2.52b / Enterprise Value 31.57b)
FCF Margin = -68.19% (FCF TTM -2.52b / Revenue TTM 3.69b)
Net Margin = 17.92% (Net Income TTM 661.5m / Revenue TTM 3.69b)
Gross Margin = 80.96% ((Revenue TTM 3.69b - Cost of Revenue TTM 702.9m) / Revenue TTM)
Gross Margin QoQ = 73.47% (prev 83.10%)
Tobins Q-Ratio = 1.17 (Enterprise Value 31.57b / Total Assets 27.06b)
Interest Expense / Debt = 1.64% (Interest Expense 207.1m / Debt 12.66b)
Taxrate = 21.71% (302.6m / 1.39b)
NOPAT = 753.8m (EBIT 962.8m * (1 - 21.71%))
Current Ratio = 0.67 (Total Current Assets 4.26b / Total Current Liabilities 6.35b)
Debt / Equity = 2.25 (Debt 12.66b / totalStockholderEquity, last quarter 5.62b)
Debt / EBITDA = 8.16 (Net Debt 9.40b / EBITDA 1.15b)
Debt / FCF = -3.74 (negative FCF - burning cash) (Net Debt 9.40b / FCF TTM -2.52b)
Total Stockholder Equity = 5.67b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.66% (Net Income 661.5m / Total Assets 27.06b)
RoE = 11.67% (Net Income TTM 661.5m / Total Stockholder Equity 5.67b)
RoCE = 5.29% (EBIT 962.8m / Capital Employed (Equity 5.67b + L.T.Debt 12.54b))
RoIC = 4.71% (NOPAT 753.8m / Invested Capital 16.01b)
WACC = 8.26% (E(22.17b)/V(34.83b) * Re(12.24%) + D(12.66b)/V(34.83b) * Rd(1.64%) * (1-Tc(0.22)))
Discount Rate = 12.24% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.15%
Fair Price DCF = unknown (Cash Flow -2.52b)
EPS Correlation: -37.59 | EPS CAGR: -44.48% | SUE: -4.0 | # QB: 0
Revenue Correlation: -3.01 | Revenue CAGR: -14.21% | SUE: -0.24 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.12 | Chg30d=-0.049 | Revisions Net=-7 | Analysts=10
EPS next Year (2026-12-31): EPS=4.71 | Chg30d=-0.092 | Revisions Net=-4 | Growth EPS=+16.9% | Growth Revenue=+23.2%